Clinical Trials on Healthy Male Subjects

Total 31648 results

Vance Fowler, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults (PROOF)

Healthy Subjects

United States
Reckitt Benckiser LLC

Completed

Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents

Healthy Subjects
Procter and Gamble

Completed

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy

Healthy Subjects

United States
Medasense Biometrics Ltd

Completed

Monitoring Changes in Physiological Parameters by Utilization of the Combined Physiological Activity Index (CPAI)

Healthy Subjects

Israel
Reckitt Benckiser Inc.

Completed

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Healthy Subjects
University of Bari

Completed

Healthy Properties of Two Almond Varieties. CEA vs. CARMEL (ALMOND1)

Healthy Subjects

Italy
Duke University

Completed

TMS Modulation of Insula-related Brain Networks.02 (TMSINS02)

Healthy Subjects

United States
Centre Hospitalier Universitaire Dijon

Completed

Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects (Fijus Raisol)

Healthy Subjects

France
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Healthy Subjects

United Kingdom
Eisai Inc.
Purdue Pharma LP

Completed

Study of Lemborexant-Alcohol Interaction in Healthy Subjects

Healthy Subjects

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Single Doses of GAP-134

Healthy Subjects
Idorsia Pharmaceuticals Ltd.

Completed

A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam

Healthy Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Completed

Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects

Healthy Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Terminated

Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441

Healthy Subjects

France
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects

Healthy Subjects

United Kingdom
Idorsia Pharmaceuticals Ltd.

Completed

A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

Healthy Subjects

Netherlands
Inotrem
Richmond Pharmacology Limited

Completed

Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects

Healthy Subjects

United Kingdom
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects

Healthy Subjects

United States
University of Minnesota

Completed

Brain-Computer Interface and Mind-Body Awareness Training

Healthy Subjects

United States
Actelion

Completed

A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects

Healthy Subjects

Germany
Hanmi Pharmaceutical Company Limited

Completed

Molar Potency Study of HM12470 in Healthy Subjects

Healthy Subjects

United States
Trius Therapeutics LLC

Completed

A Phase 1, Open-Label, 10 Day Safety Study

Healthy Subjects

United States
Kirk A. Frey
Adeptio Pharmaceuticals

Completed

(+)-Alpha-Dihydrotetrabenazine Phase I

Healthy Subjects

United States
Spaulding Rehabilitation Hospital

Completed

Robotic Assessment of Lower Extremity Motor Learning

Healthy Subjects

United States
University of North Carolina, Chapel Hill
Gilead Sciences

Completed

Study to Characterize the Durability of Hypertonic Saline to Enhance Mucociliary Clearance in Healthy Subjects

Healthy Subjects

United States
Katarina Kos
University of Exeter

Terminated

Incretin and KATP Channels

Healthy Subjects

United Kingdom
ViiV Healthcare

Completed

GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study

Healthy Subjects

United States
Astellas Pharma Inc
FibroGen

Completed

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Healthy Subjects

Japan
Torrent Pharmaceuticals Limited

Completed

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Healthy Subjects
University of California, San Francisco

Completed

Effect of Clemastine Fumarate on Color Vision in Healthy Controls

Healthy Subjects

United States
Actelion

Completed

A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects

Healthy Subjects

United Kingdom
Actelion

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects

Healthy Subjects

United Kingdom
Orexigen Therapeutics, Inc

Completed

Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants

Healthy Subjects
Medical University of Vienna

Unknown

The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS (INTO_humans)

Healthy Subjects

Austria
Aerie Pharmaceuticals

Completed

A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers

Healthy Subjects

United States
Astellas Pharma Inc

Completed

Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects

Healthy Subjects

Japan
Astellas Pharma Inc
FibroGen

Completed

A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517

Healthy Subjects

Japan
Wockhardt
Quintiles, Inc.

Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Healthy Subjects

United States
Actelion

Completed

A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

Healthy Subjects

Germany
GlaxoSmithKline

Withdrawn

A Study to Compare Two Paracetamol Tablets

Healthy Subjects

United Kingdom
Lund University
Göteborg University

Completed

Effects of Barley Based Food Products on Metabolism and Gut Microflora

Healthy Subjects

Sweden
University Hospital, Linkoeping

Completed

Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects

Healthy Subjects

Sweden
Yonsei University

Completed

Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults

Healthy Subjects

Korea, Republic of
Cuda Anesthetics, LLC

Completed

Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

Healthy Subjects
New Mexico Cancer Care Alliance
Oxnard Foundation

Terminated

Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells

Healthy Subjects

United States
Charite University, Berlin, Germany

Completed

Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Younger, Healthy Subjects

Healthy Subjects

Germany
AstraZeneca

Completed

To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.

Healthy Subjects

United Kingdom
Eisai Inc.

Completed

An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects

Healthy Subjects

United States
Pfizer

Completed

A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects

Healthy Subjects

Belgium

3

Subscribe